APA (7th ed.) Citation

Rücker, F. G., Bullinger, L., Cocciardi, S., Skambraks, S., Luck, T. J., Weber, D., . . . Döhner, K. (2023, August). S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN. HemaSphere.

Chicago Style (17th ed.) Citation

Rücker, Frank G., et al. "S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN." HemaSphere Aug. 2023.

MLA (9th ed.) Citation

Rücker, Frank G., et al. "S135: NEXT-GENERATION SEQUENCING-BASED MEASURABLE RESIDUAL DISEASE MONITORING IN ACUTE MYELOID LEUKEMIA WITH FLT3 INTERNAL TANDEM DUPLICATION TREATED WITH INTENSIVE CHEMOTHERAPY PLUS MIDOSTAURIN." HemaSphere, Aug. 2023.